News

Combo Topical Therapy, Cryosurgery May Beat Excision


 

RHODES, GREECE — Combining topical immunomodulatory therapy or topical chemotherapy with cryosurgery provides an excellent alternative to excisional treatment for many skin malignancies, Dr. Paola Pasquali said at the 15th Congress of the European Academy of Dermatology and Venereology.

Cryosurgery itself represents an excellent option for many skin malignancies, including most basal cell carcinomas. Exceptions include morpheaform, metatypical, and neurotropic basal cell carcinomas, for which Mohs surgery is preferable. Cryosurgery is also beneficial for well-differentiated squamous cell carcinomas and lentigo maligna, she said.

The use of the immune response modifier imiquimod before any surgical intervention can improve local immune response and reduce treatment areas. Cryosurgery can then be used to treat areas that failed to respond, said Dr. Pasquali, a dermatologist in private practice in Caracas, Venezuela.

This approach is particularly useful in patients with severe sun damage with multiple actinic keratoses or superficial basal cell carcinomas, she said, noting that she has her patients use imiquimod 5 days a week for 6 weeks, followed by cryotherapy for remaining lesions.

This reduces the need for surgical treatment and provides a better cosmetic outcome, she said.

For nodular basal cell carcinomas, biopsy and curettage is performed, and the lesion is allowed to heal before imiquimod treatment is initiated and cryosurgery is used to treat remaining lesions.

Topical chemotherapy with the antimetabolite 5-fluorouracil can also be used along with cryosurgery in some patients, such as those with actinic keratoses or Bowen's disease.

As with imiquimod, the topical treatment is used to reduce the number and size of lesions and the remaining lesions are treated with cryosurgery.

These combinations also are useful for palliation in patients with large tumors, Dr. Pasquali noted.

This female patient had a hypertrophic actinic keratosis that was associated with a squamous cell carcinoma and severe actinic damage.

Improvement was evident after cryosurgery of the nodular lesion and treatment with imiquimod on the rest of the patient's damaged skin. Photos Courtesy Dr. Paola Pasquali

Recommended Reading

Verteporfin, PDL Treat Port-Wine Stains
MDedge Dermatology
Establish Boundaries With Cosmetics Patients
MDedge Dermatology
Patients Report Satisfaction, Some Pain With Fraxel
MDedge Dermatology
Anesthesia, Suture Advice Top Procedural Pearls for Defect Closure
MDedge Dermatology
Pneumatic Device Touted as Hair-Removal Pain Reliever
MDedge Dermatology
Tumescent Anesthesia Not Just for Liposuction
MDedge Dermatology
Use of Individual Components and Advances in Topical Formulation Technology: Focus on Corticosteroids
MDedge Dermatology
Sunless Tanning: A Review
MDedge Dermatology
The Influence of Ethnicity, Gender, and Fitzpatrick Skin Type on High School Students' Ultraviolet Light Risk Awareness and Behavior
MDedge Dermatology
Imiquimod 5% Cream Reverses Histologic Changes and Improves Appearance of Photoaged Facial Skin
MDedge Dermatology